Evidence map›Paper›PMID 42289053›Full record

ArticleBriefings in bioinformatics2026

MMP3C v2: a network-based framework decoding metabolic plasticity in rheumatoid arthritis, enabling accurate diagnosis and uncovering cell-type-specific metabolic rewiring.

Xingyu Chen, Zihan Wang, Min Deng, Jianxiang Huang, Naishu Zhang, Zheng Wu, Zelin Yi, Sangyu Li, Jiayue Qiu, Kit-Leong Cheong and 2 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xingyu ChenDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Zihan WangDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Min DengCRDA, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China.
Jianxiang HuangDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Naishu ZhangDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Zheng WuDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Zelin YiDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Sangyu LiDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Jiayue QiuDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.
Kit-Leong CheongCollege of Food Science and Technology, Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, Guangdong Ocean University, No. 1 Haida Road, Mazhang District, Zhanjiang City, Guangdong Province 524088, China.
Xin ChenSchool of Automation, Guangdong University of Technology, No. 100 Waihuan Xi Road, Guangzhou Higher Education Mega Center, Panyu District, Guangzhou, Guangdong Province 510006, China.ORCID 0000-0001-7234-8135
Chen HuangDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR 999078, China.ORCID 0000-0002-7092-7587

Funding

General Research Grants of Macau University of Science and Technology FRG-21-032-SKLThe Science and Technology Development Fund 0003/2025/NRPThe Science and Technology Development Fund 002/2023/ALCThe Science and Technology Development Fund 006/2023/SKL
6 · The paper itself

Abstract

Metabolic plasticity, the ability of cells to dynamically adapt their metabolic pathways in response to changing environments, is a hallmark of rheumatoid arthritis (RA) pathogenesis and plays a critical role in immune dysfunction. However, scalable methods to quantify inter-pathway crosstalk in RA remain lacking. To address this gap, we present MMP3C v2, an updated network-based framework that integrates gene expression with protein-protein interaction network topology to compute directed pairwise metabolic plasticity (PMP) scores. We applied MMP3C v2 to ~3400 bulk transcriptomes (RA, osteoarthritis, systemic lupus erythematosus, and healthy controls) and ~228 000 single-cell transcriptomics from blood and synovium to profile RA-associated PMP alterations and develop diagnostic classifiers. We found that a single PMP-derived signature demonstrated strong predictive capability for diagnosis. Then, we developed a feature selection pipeline and combined it with 110 machine learning model combinations, by which we established the optimal ensemble classifier (stepwise forward selection + ridge regression), achieving robust and generalized performance (mean area under the curve (AUC) = 0.935; mean F1 score = 0.915) across 12 independent validation cohorts, outperforming seven previously published models. Single-cell analysis revealed cell-type-specific PMP remodeling: a Warburg-like shift in synovial macrophages (↑glycolysis, ↑pentose phosphate pathway, ↓oxidative phosphorylation). Cell-cell communication analysis highlighted FN1-centered signaling linked to glucose metabolic remodeling in myofibroblasts. Collectively, MMP3C v2 establishes metabolic pathway crosstalk as a core diagnostic feature of RA, enabling interpretable and cross-platform diagnostic modeling and the identification of cell-type-specific PMP patterns. The open-source R package mmp3c supports reproducible analysis and broad application.

Indexed as

Arthritis, RheumatoidMatrix Metalloproteinase 3Metabolic Networks and PathwaysHumansMachine LearningMetabolic ReprogrammingProtein Interaction MapsTranscriptomeMatrix Metalloproteinase 3biomarkerdiagnosismetabolic plasticityrheumatoid arthritisscRNA-seq

Identifiers

PMID42289053
PMCPMC13264964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.